Leadership Transitions at ONWARD Medical
ONWARD Medical N.V., a pioneering medical technology firm focused on spinal cord stimulation therapies, has exciting leadership updates. This renowned company is at the forefront of innovation, and with these changes, it is setting the stage for significant advancements.
Rob ten Hoedt Joins as Incoming Chairman
As part of its strategic evolution, ONWARD Medical is thrilled to announce the addition of Rob ten Hoedt to its Board of Directors. Ten Hoedt, an esteemed leader previously associated with Medtronic, is recognized for his extensive expertise in technology development and his impactful leadership within the medtech industry.
His previous roles include Executive Vice-President and President of Global Regions at Medtronic, where he was instrumental in spearheading initiatives that benefited patients worldwide. Ten Hoedt also served as Chairman of MedTech Europe, where he contributed to the growth and development of the medical technology sector across Europe.
Scheduled to step into the role of Chairman later this year, Ten Hoedt stated, "I am honored and excited to join this exceptional company. I look forward to collaborating with the Board and Management to harness ONWARD's immense potential in addressing unmet medical needs in spinal cord injury treatment." His expected contributions to ONWARD Medical include leveraging his vast network and innovative mindset.
Rahma Samow's Appointment as Director
Joining Ten Hoedt is Rahma Samow, a prominent figure in commercial and digital health. Currently the President and CEO of ClearChoice Dental Implant Centers, Samow brings a wealth of experience from her time on the Executive Management Board at Straumann Group and a notable tenure at Siemens Healthineers.
Samow's extensive background in global sales, marketing, and promotion of digital health initiatives will enhance ONWARD Medical's strategic direction. Dave Marver, CEO of ONWARD Medical, expressed enthusiasm about her appointment, stating, "Rahma's expertise will help us build strong communities among those we serve and enable us to navigate the challenges of commercializing our therapies globally."
Retirement of Long-Standing Board Members
These strategic appointments come as ONWARD bids farewell to its current Chairman Jan Ohrstrom and Director Fred Colen, who will retire after eight years of committed service. Marver acknowledged their invaluable contributions, stating: "Jan has provided unwavering guidance, and Fred's deep industry experience has been crucial for our growth. They have both played an instrumental role in our evolution from a startup to a publicly traded company ready for commercialization."
This transition marks a pivotal moment for ONWARD Medical as it prepares for the upcoming launch of its innovative ARC-EX System in the United States. This system is currently undergoing FDA review, and with the support and experience of Ten Hoedt and Samow, ONWARD is poised for an exciting new chapter.
Commitment to Innovation in Spinal Cord Injury Treatment
ONWARD Medical is dedicated to partnering with the spinal cord injury community, continuously focused on developing effective therapeutic solutions. Its acclaimed ARC therapy has garnered significant attention, receiving numerous Breakthrough Device Designations from the FDA, indicating its potential to truly impact patients' lives.
The company’s research on ARC Therapy focuses on targeted spinal cord stimulation designed to restore movement and function. The ongoing clinical studies, such as the pivotal Up-LIFT trial, have shown promising results in improving upper limb function for individuals with spinal cord injuries.
With headquarters in Eindhoven and operations expanded to Lausanne and Boston, ONWARD Medical exemplifies a global commitment to innovation, collaborating with leading hospitals and universities to propel its mission forward.
Frequently Asked Questions
What recent changes occurred in ONWARD Medical's leadership?
ONWARD Medical appointed Rob ten Hoedt as the new incoming Chairman and Rahma Samow as a member of the Board of Directors.
Who is Rob ten Hoedt?
Rob ten Hoedt is a former executive at Medtronic and has extensive experience in the medtech industry, bringing valuable insights to ONWARD Medical.
What are the main goals for ONWARD Medical moving forward?
ONWARD aims to launch its ARC-EX System while enhancing its therapeutic offerings in spinal cord injury treatment and increasing its market presence.
What is ARC Therapy?
ARC Therapy is an innovative spinal cord stimulation method aimed at restoring movement and functionality for those affected by spinal cord injuries.
How is ONWARD Medical ensuring patient-centered care?
ONWARD Medical is committed to partnering with the spinal cord injury community and engaging in ongoing research to meet specific needs and improve patient outcomes.
